Terazosin hydrochloride

Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH).

Target : Adrenergic Receptor

CAS Number : 63074-08-8

Formula Weight : 423.89

Molecular Formula : C19H26ClN5O4

Purity : >98%(HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.